FDA Approves New Gilead HIV Pill

By

Jennifer Corbett Dooren

Aug. 27, 2012 5:39 p.m. ET

The Food and Drug Administration on Monday approved a new Gilead Sciences Inc. HIV medicine that combines four ingredients into one pill.

The product, previously called Quad, will be sold under the brand name Stribild. It is meant to treat people infected with human immunodeficiency virus who haven't been previously treated with other HIV medicines.

The agency said Stribild provides a complete treatment regimen for HIV...